These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 18065810

  • 1. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.
    Hu W, Liu C, Xie H, Chen H, Liu Z, Li L.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil as maintenance therapy in patients with vasculitis and renal involvement.
    Iatrou C, Zerbala S, Revela I, Spanou E, Marinaki S, Nakopoulou L, Boletis J.
    Clin Nephrol; 2009 Jul; 72(1):31-7. PubMed ID: 19640385
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial.
    Jones RB, Hiemstra TF, Ballarin J, Blockmans DE, Brogan P, Bruchfeld A, Cid MC, Dahlsveen K, de Zoysa J, Espigol-Frigolé G, Lanyon P, Peh CA, Tesar V, Vaglio A, Walsh M, Walsh D, Walters G, Harper L, Jayne D, European Vasculitis Study Group (EUVAS).
    Ann Rheum Dis; 2019 Mar; 78(3):399-405. PubMed ID: 30612116
    [Abstract] [Full Text] [Related]

  • 4. A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis.
    Joy MS, Hogan SL, Jennette JC, Falk RJ, Nachman PH.
    Nephrol Dial Transplant; 2005 Dec; 20(12):2725-32. PubMed ID: 16188901
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission in Nonlife-Threatening Relapses of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Randomized, Controlled Trial.
    Tuin J, Stassen PM, Bogdan DI, Broekroelofs J, van Paassen P, Cohen Tervaert JW, Sanders JS, Stegeman CA.
    Clin J Am Soc Nephrol; 2019 Jul 05; 14(7):1021-1028. PubMed ID: 31253599
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.
    Silva F, Specks U, Kalra S, Hogan MC, Leung N, Sethi S, Fervenza FC.
    Clin J Am Soc Nephrol; 2010 Mar 05; 5(3):445-53. PubMed ID: 20093349
    [Abstract] [Full Text] [Related]

  • 7. Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide.
    Stassen PM, Tervaert JW, Stegeman CA.
    Ann Rheum Dis; 2007 Jun 05; 66(6):798-802. PubMed ID: 17179175
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis.
    Koukoulaki M, Jayne DR.
    Nephron Clin Pract; 2006 Jun 05; 102(3-4):c100-7. PubMed ID: 16286784
    [Abstract] [Full Text] [Related]

  • 9. Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients.
    Wendt M, Gunnarsson I, Bratt J, Bruchfeld A.
    Scand J Rheumatol; 2012 Mar 05; 41(2):116-9. PubMed ID: 22118245
    [Abstract] [Full Text] [Related]

  • 10. Treatment of acute c-ANCA-positive vasculitis with mycophenolate mofetil.
    Waiser J, Budde K, Braasch E, Neumayer HH.
    Am J Kidney Dis; 1999 Sep 05; 34(3):e9. PubMed ID: 10471756
    [Abstract] [Full Text] [Related]

  • 11. Factors influencing patient survival and renal function outcome in pulmonary-renal syndrome associated with ANCA (+) vasculitis: a single-center experience.
    Stangou M, Asimaki A, Bamichas G, Christidou F, Zoumbaridis N, Natse T, Galanis N, Christaki P, Patakas D, Sombolos K.
    J Nephrol; 2005 Sep 05; 18(1):35-44. PubMed ID: 15772921
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of mycophenolate mofetil as a remission induction therapy in antineutrophil cytoplasmic antibody: associated vasculitis-a meta-analysis.
    Kuzuya K, Morita T, Kumanogoh A.
    RMD Open; 2020 Apr 05; 6(1):. PubMed ID: 32371435
    [Abstract] [Full Text] [Related]

  • 13. Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
    Wang J, Hu W, Xie H, Zhang H, Chen H, Zeng C, Liu Z, Li L.
    Lupus; 2007 Apr 05; 16(9):707-12. PubMed ID: 17728363
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate mofetil in anti-MPO renal vasculitis: an alternative therapy in case of cyclophosphamide or azathioprine toxicity.
    Ibernon M, Poveda R, Vidaller A, Bestard O, Grinyó JM.
    Clin Nephrol; 2008 Jun 05; 69(6):395-401. PubMed ID: 18538114
    [Abstract] [Full Text] [Related]

  • 15. Use of mycophenolate in ANCA-associated renal vasculitis: 13 years of experience at a university hospital.
    Draibe J, Poveda R, Fulladosa X, Vidaller A, Zulberti C, Gomà M, Pujol R, Ripoll È, Torras J, Grinyó JM.
    Nephrol Dial Transplant; 2015 Apr 05; 30 Suppl 1():i132-7. PubMed ID: 25805744
    [Abstract] [Full Text] [Related]

  • 16. Effects of mycophenolate mofetil for patients with crescentic lupus nephritis.
    Tang Z, Yang G, Yu C, Yu Y, Wang J, Hu W, Zeng C, Chen H, Liu Z, Li L.
    Nephrology (Carlton); 2008 Dec 05; 13(8):702-7. PubMed ID: 18771470
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study.
    Jayne D, Blockmans D, Luqmani R, Moiseev S, Ji B, Green Y, Hall L, Roth D, Henderson RB, Merkel PA, BREVAS Study Collaborators.
    Arthritis Rheumatol; 2019 Jun 05; 71(6):952-963. PubMed ID: 30666823
    [Abstract] [Full Text] [Related]

  • 18. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
    Slot MC, Tervaert JW, Boomsma MM, Stegeman CA.
    Arthritis Rheum; 2004 Apr 15; 51(2):269-73. PubMed ID: 15077271
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis.
    Kazderova M, Jancova E, Rysava R, Merta M, Tesar V.
    Arch Med Res; 2008 Jan 15; 39(1):115-9. PubMed ID: 18068004
    [Abstract] [Full Text] [Related]

  • 20. Tolerance of mycophenolate mofetil in end-stage renal disease patients with ANCA-associated vasculitis.
    Haubitz M, de Groot K.
    Clin Nephrol; 2002 Jun 15; 57(6):421-4. PubMed ID: 12078944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.